EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force

By P. Andersen, S. Abrahams, G. Borasio, M. de Carvalho, A. Chiò, P. van Damme, O. Hardiman, K. Kollewe, K. Morrison, S. Petri and 5 more. European Journal of Neurology, 2012

1,090 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Neurology, Speech and Hearing

View Paper: https://www.semanticscholar.org/paper/e6fdfb29b7569684043432726b32589f27ecdfd3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Pegah Masrori
2. P. van Damme

Citations in the corpus

• Amyotrophic lateral sclerosis: a clinical review (2020, background): “The cornerstone of disease management for ALS patients remains multidisciplinary care which has a positive effect on patient satisfaction and outcome [83].”
• A comprehensive review of amyotrophic lateral sclerosis (2015, background): “Differential diagnosis Lack of disease progression, an unusual patient history, or uncommon symptoms should prompt further investigation of the differential diagnosis of ALS [Table 1].[84,115,295]”